TechConnect Innovation Program

Novel therapeutic for the treatment of ocular pathologies

LSU Health Sciences Center - New Orleans, Louisiana, United States

TECHNOLOGY SUMMARY

This technology is a treatment for corneal tissue pathology following viral infection, medical procedures, and accidental injury. Demonstrated by extensive testing in an in vivo rabbit eye system, the therapeutic has a strong anti-viral effect, is a potent anti-inflammatory agent, and has an anti-angiogenic effect while simultaneously promoting corneal healing.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Prototype

Technology Readiness Level:

FIGURES OF MERIT

Value Proposition:

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 737

Website: www.lsuhsc.edu

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: